Pharma M&A Deals Q3 2025 – Top Themes: Strategic Intelligence
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
This report analyzes the disruptive themes that have driven M&A activity in Q3 2025 in the pharma Sector.
Scope
This report provides an overview of merger and acquisition activity globally in Q3 2025 in Pharma Sector
It identifies the themes driving most notable to deals announced in Q3 2025 in the Pharma Sector
Key Highlights
The global pharma sector in Q3 2025 witnessed deals worth $43 billion, a growth of 30% compared to Q3 2024. The Pharma sector recorded deal value worth $34 billion mega deals (defined as any deal valued at more than $1 billion) in Q3 2025, an increase of 67% compared to Q3 2024.
Reasons to Buy
Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).
In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Genmab AS
Pfizer Inc
F. Hoffmann-La Roche Ltd
Innosera ApS
Sanofi
Novartis AG
AbbVie Inc
Sino Biopharmaceutical Ltd
Royalty Pharma Plc
Lotus US Financing S.a r.l
Otsuka Pharmaceutical Co Ltd
Les Laboratoires Servier SAS
Bausch Health Companies Inc
Serb SAS
Sanofi
Concentra Biosciences LLC
MannKind Corp
Kite Pharma Inc
Celltrion Inc
Verona Pharma Plc
Merus NV
Metsera Inc
89bio Inc
Bavarian Nordic AS
Vicebio Ltd
Tourmaline Bio Inc
Gilgamesh Pharmaceuticals Inc
LaNova Medicines Ltd
BeOne Medicines
Alvogen Inc
Cantargia
Kaerus Bioscience
DURECT Corp
Y-mAbs Therapeutics Inc
Visirna Therapeutics
iTeos Therapeutics Inc
scPharmaceuticals Inc
Interius BioTherapeutics Inc
Eli Lilly
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals reports